WuXi XDC

Thought Leadership: Dr. Jun Hu, Vice President, Head of Client Enabling Center of Excellence & Head of Singapore Site Management at WuXi XDC, was recently invited by IMAPAC to discuss key insights in the field of ADC & Bioconjugates. 💡 Challenges in ADC development – Key considerations at various stages, including CMC development and manufacturing obstacles 💡 The Role of CRO/CDMOs – How CRO/CDMOs enable ADC development and what to look for when choosing the right partner 💡 WuXi XDC as a global leading CRDMO – The indispensable value WuXi XDC brings to the industry 💡 Singapore Site Strategy – Insights into the strategic progress of WuXi XDC’s new Singapore facility 💡 Future of ADCs – Dr. Hu’s perspective on current trends and future prospects in ADC and bioconjugates development View the full interview here 👉 https://lnkd.in/gu2dY2bH

From library screening and leads generation to preclinical candidate (PCC) selection, we provide tailored linker-payload optimization and selection services to advance your path to success. Learn more: https://lnkd.in/gMqxP3Gb #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #antibodydrugconjugate #Payload #Payloadlinker

🎉 Reflecting on the 2025 SAPA-GP Annual Conference! The 2025 SAPA-GP (Sino-American Pharmaceutical Professionals Association -Greater Philadelphia) Annual Conference has come to a successful close, and we are grateful to have been part of this dynamic and inspiring event. It was an honor to connect with a diverse group of accomplished industry leaders, fostering meaningful discussions and exchanging ideas that are driving the future of the bioconjugates industry. This experience has been invaluable, providing us with fresh insights and inspiration that will fuel our ongoing commitment to innovation and growth. As we look ahead, we are excited to deepen these connections and explore new opportunities for collaboration. Let’s continue the conversation and unlock the potential of working together. Reach out to us anytime: https://lnkd.in/eCgHTVqf #SAPAGP2025AC #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing #cmc

Dr. Jimmy Li Shines at the 2025 SAPA-GP Annual Conference! This week at the 2025 SAPA-GP Annual Conference. During the ADC-focused session co-organized by the Chinese Antibody Society and SAPA-GP (Sino-American Pharmaceutical Professionals Association -Greater Philadelphia), Dr. Jimmy Li, CEO of WuXi XDC, delivered an insightful presentation titled “Accelerating the Development of ADCs from Concept to BLA.” His talk sparked lively and engaging discussions among the audience, highlighting the critical role of innovation and collaboration in advancing ADC development. We extend our heartfelt gratitude to everyone who attended Dr. Li’s presentation—your support and enthusiasm are truly appreciated. If you’d like to explore how we can support your bioconjugate projects, we’d love to connect. Reach out to us here: https://lnkd.in/eCgHTVqf #SAPAGP2025AC #conjugate #adc #bioconjugate #cdmo #cro

🎉Highlights from the ADC Asia Congress 2025 IMAPAC and Biologics Manufacturing Asia 2025! The exhilarating ADC Asia Congress 2025 and Biologics Manufacturing Asia 2025 were overflowing with innovation and abuzz with intellectual clashes! Dr. Jun Hu, Vice President, Head of Client Enabling Center of Excellence & Head of Singapore Site Management at WuXi XDC, delivered an insightful and thought-provoking presentation titled “Accelerate Bioconjugate Development with WuXi XDC’s Fully Integrated Capabilities and Expanding Global Capacity.” Dr. Hu highlighted the rapid growth and immense potential of ADC and XDC development in the global pharmaceutical industry, and then showcased WuXi XDC’s integrated service platform and innovative technologies, which serve as a powerful engine to accelerate bioconjugate development. Additionally, he also shared WuXi XDC’s ongoing efforts to expand its global footprint, ensuring enhanced support for partners worldwide. During the WuXi BioInnovate Luncheon at Biologics Manufacturing Asia 2025, Dr. Hu hosted a panel session on “Overcoming CMC Bottlenecks: The Future of Manufacturing Strategies.” The panel engaged in a lively discussion about the most formidable CMC bottlenecks that biopharmaceutical companies encounter during the drug development process. They also explored Technology Innovation and how to identify bottlenecks early and, through collaboration, how to evaluate/select appropriate external partners when dealing with CMC bottlenecks and help reduce risks and costs in drug development and commercialization. We extend our heartfelt gratitude to everyone who participated in our session and engaged in those rich discussions. Your engagement and interest are deeply appreciated. Let’s stay connected and explore how we can support your bioconjugate development needs. Reach out to us now: https://lnkd.in/eCgHTVqf #ADCAsia #conjugate #bioconjugate #antibodydrugcongugate #cmc #cdmo #crdmo #biomanufacturing #bioprocessing

📣 Join Us for an Exclusive Webinar on Accelerating ADC & XDC Development with Novel Linker Technologies！Register now to secure your spot: https://lnkd.in/gYv8Cnyw Mark your calendars for March 27th and don’t miss our upcoming webinar: “Bridging ‘Small’ Molecules with ‘Big’ Molecules: Accelerating ADCs & XDCs Discovery and Development with Novel Linker Technologies.” Led by Dr. Jingjie Huang, this session is a must-attend for anyone exploring the cutting edge of linker/connector technologies. Dr. Huang will dive into innovative linker technologies that can modulate the physicochemical properties of ADCs and XDCs, enhancing their druggability and significantly accelerating discovery and development timelines. This is your opportunity to gain valuable insights and stay ahead in the rapidly evolving field of bioconjugates. 💡 Webinar: Bridging “Small” Molecules with “Big” Molecules: Accelerating ADCs & XDCs Discovery and Development with Novel Linker Technologies 👤 Speaker: Dr. Jingjie Huang, Head of Payload-Linker Discovery Service, WuXi XDC 📅 March 27, 11:00 AM EDT, 4:00 PM CET #linker #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing

Join us in celebrating WuXi XDC's spectacular triumphs at the 2025 Asia - Pacific Biopharma Excellence Awards！IMAPAC WuXi XDC has been recognized with four prestigious awards: 🏆 Best ADC CDMO in China 🏆 Best ADC CDMO in Asia 🏆 Best ADC CRO in Asia 🏆 Best ADC Platform Technology We are honored to receive these prestigious awards, which not only reaffirm our team’s relentless pursuit of excellence and innovation in the ADC field but also underscore our dedication to delivering world-class services that empower our clients to bring novel therapies to patients worldwide. Looking ahead, WuXi XDC will continue to support our clients and advance the innovation and progress of the global bioconjugate industry！ #conjugate #bioconjugate #antibodydrugcongugate #cmc #cdmo #crdmo #biomanufacturing #bioprocessing

WuXi XDC Cayman Inc. (“WuXi XDC”, or the “Company”, stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with four prestigious awards at the Asia-Pacific Biopharma Excellence Awards 2025 IMAPAC. The Asia-Pacific Biopharma Excellence Awards honor companies annually that have exhibited outstanding performance and achievement in the biopharmaceutical sector. These accolades underscore WuXi XDC’s leadership, innovation, and fully integrated CRDMO platform, empowering global clients from early discovery to commercial manufacturing. More detailed information about this collaboration is available from the following link. https://shorturl.at/aa3gT

🎉 Celebrating Innovation at the 53rd Organic Process Research & Development Conference! Scientific Update Ltd This week, we had the honor of sponsoring and participating in the 53rd Organic Process Research & Development Conference in Charleston, SC, USA. It was an incredible opportunity to connect with industry leaders, showcase cutting-edge advancements, and explore the future of organic process research. Engaging in meaningful discussions, sharing breakthrough insights, and building valuable partnerships reaffirmed our commitment to driving innovation in this dynamic field. We are proud to have been part of such a prestigious event and to contribute to the ongoing evolution of the industry. Let’s continue the conversation and stay connected! Reach out to us at: https://lnkd.in/eCgHTVqf #OPRD #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing #PayloadLinker

Join Us at CPHI Japan in Tokyo – April 9-11 We are excited to invite you to CPHI Japan, taking place in Tokyo from April 9 to 11. Don’t miss the opportunity to hear from Dr. Xudong Wei, Senior Vice President and Head of Payload Linker PD & Manufacturing at WuXi XDC, as he delivers an insightful presentation on April 9. Dr. Wei’s session, titled “Synthesis of Payload-Linkers for Conjugated Drugs: Key Elements of Successful CMC Work,” will provide in-depth and practical knowledge on the synthesis of payload-linkers—a critical component in the development of conjugated drugs. He will also share valuable insights into the key factors that drive successful Chemistry, Manufacturing, and Controls (CMC) strategies. We look forward to connecting with you at the event! Let’s schedule a meeting to discuss how we can collaborate: https://lnkd.in/guvvwrnY #CPHI #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing #PayloadLinker